News
The Chosun Ilbo on MSN
Healthy seniors see no long-term cardiovascular benefit from aspirin
Cardiovascular diseases, represented by myocardial infarction and cerebral infarction, are primarily caused by narrowed ...
Compared with dual antiplatelet therapy (DAPT), a de-escalated DAPT strategy resulted in similar graft occlusion rates and ...
Compared with dual antiplatelet therapy (DAPT), a de-escalated DAPT strategy resulted in similar graft occlusion rates and reduced clinically relevant ...
Adding ticagrelor to aspirin appears to carry benefits, at least early on, but also ups bleeding—de-escalation could be a fix ...
MADRID, Spain—Adding evolocumab (Repatha; Amgen) to statin therapy does not lower the risk of saphenous vein graft (SVG) ...
In cardiogenic shock, the heart is unable to pump sufficient blood to supply vital organs. Cardiogenic shock is the leading cause of death in patients with acute myocardial infarction (MI). The ...
Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes ...
Research from a Monash University-led team has confirmed 2018 research that found healthy older adults who took a low-dose of aspirin daily experienced a higher risk of a major haemorrhage without any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback